Does TRILACICLIB Cause Infusion site pain? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Infusion site pain have been filed in association with TRILACICLIB (COSELA). This represents 4.0% of all adverse event reports for TRILACICLIB.
9
Reports of Infusion site pain with TRILACICLIB
4.0%
of all TRILACICLIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Infusion site pain From TRILACICLIB?
Of the 9 reports, 1 (11.1%) required hospitalization.
Is Infusion site pain Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Performance status decreased (14)
Death (13)
Infection (12)
What Other Drugs Cause Infusion site pain?
TREPROSTINIL (5,169)
HUMAN IMMUNOGLOBULIN G (1,915)
AMBRISENTAN (624)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (285)
MACITENTAN (282)
INSULIN LISPRO-AABC (248)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (230)
INFLIXIMAB (186)
INFLIXIMAB-DYYB (178)
SELEXIPAG (171)
Which TRILACICLIB Alternatives Have Lower Infusion site pain Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE